Bioverge Portfolio

  • Personalized microbiome health services & data platform

    Seed
    • $2.5M annualized revenue
    • Clinical-grade data and quality control
    • Strategic investment by Unilever, Walton Family
    Explore
    Offered By: Bioverge Funds Management LLC

    Revolutionizing Preclinical Drug Discovery

    Seed
    • $21 billion market opportunity
    • Saas model w/ 2019 rev. of $272K
    • >30 paying customers, including global pharma
    Explore
    Offered By: Bioverge Funds Management LLC

    Revolutionizing the way the world views science

    Seed
    Series A
    Pre-B Bridge
    • $8.2 billion global market opportunity
    • Award-winning products with $22 million in sales
    • New products in R&D for advanced applications
    Explore
    Offered By: Bioverge Funds Management LLC
The Bioverge platform is host to both Regulation Crowdfunding and Regulation D offering types. Reg CF offerings are provided by Bioverge Portal LLC and Reg D offering are provided by Bioverge Funds Management LLC. Companies designated as BV Showcase are enrolled in a program managed by Bioverge Inc and are not associated with an offering on the Bioverge platform.
Bioverge final lockup white
We use cookies to improve your experience on our site . By continuing to browse, you agree to our use of cookies, privacy policy , and terms of services.
I'm OK with that
I refuse cookies